Teva Pharmaceutical Statistics
Total Valuation
TEVA has a market cap or net worth of $20.16 billion. The enterprise value is $34.94 billion.
Important Dates
The last earnings date was Wednesday, January 29, 2025, before market open.
| Earnings Date | Jan 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TEVA has 1.13 billion shares outstanding. The number of shares has increased by 1.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 68.34% |
| Float | 1.13B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.02 |
| PS Ratio | 1.27 |
| Forward PS | 1.18 |
| PB Ratio | 3.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 26.91 |
| P/OCF Ratio | 16.16 |
| PEG Ratio | 1.49 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.46, with an EV/FCF ratio of 46.64.
| EV / Earnings | n/a |
| EV / Sales | 2.11 |
| EV / EBITDA | 11.46 |
| EV / EBIT | 17.56 |
| EV / FCF | 46.64 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 3.36.
| Current Ratio | 0.98 |
| Quick Ratio | 0.50 |
| Debt / Equity | 3.36 |
| Debt / EBITDA | 5.67 |
| Debt / FCF | 24.14 |
| Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is -29.01% and return on invested capital (ROIC) is 4.79%.
| Return on Equity (ROE) | -29.01% |
| Return on Assets (ROA) | 3.00% |
| Return on Invested Capital (ROIC) | 4.79% |
| Return on Capital Employed (ROCE) | 7.50% |
| Revenue Per Employee | $437,082 |
| Profits Per Employee | -$43,301 |
| Employee Count | 37,851 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, TEVA has paid $676.00 million in taxes.
| Income Tax | 676.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.67% in the last 52 weeks. The beta is 0.73, so TEVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +55.67% |
| 50-Day Moving Average | 19.55 |
| 200-Day Moving Average | 17.56 |
| Relative Strength Index (RSI) | 32.87 |
| Average Volume (20 Days) | 11,286,914 |
Short Selling Information
| Short Interest | 15.80M |
| Short Previous Month | 23.22M |
| Short % of Shares Out | 1.40% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.26 |
Income Statement
In the last 12 months, TEVA had revenue of $16.54 billion and -$1.64 billion in losses. Loss per share was -$1.45.
| Revenue | 16.54B |
| Gross Profit | 8.06B |
| Operating Income | 1.99B |
| Pretax Income | 131.00M |
| Net Income | -1.64B |
| EBITDA | 3.05B |
| EBIT | 1.99B |
| Loss Per Share | -$1.45 |
Full Income StatementBalance Sheet
The company has $3.30 billion in cash and $18.08 billion in debt, giving a net cash position of -$14.78 billion or -$13.03 per share.
| Cash & Cash Equivalents | 3.30B |
| Total Debt | 18.08B |
| Net Cash | -14.78B |
| Net Cash Per Share | -$13.03 |
| Equity (Book Value) | 5.38B |
| Book Value Per Share | 4.74 |
| Working Capital | -244.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.25 billion and capital expenditures -$498.00 million, giving a free cash flow of $749.00 million.
| Operating Cash Flow | 1.25B |
| Capital Expenditures | -498.00M |
| Free Cash Flow | 749.00M |
| FCF Per Share | $0.66 |
Full Cash Flow StatementMargins
Gross margin is 48.74%, with operating and profit margins of 12.02% and -9.91%.
| Gross Margin | 48.74% |
| Operating Margin | 12.02% |
| Pretax Margin | -7.76% |
| Profit Margin | -9.91% |
| EBITDA Margin | 18.42% |
| EBIT Margin | 12.02% |
| FCF Margin | 4.53% |